| Year |
Citation |
Score |
| 2014 |
Eckerdt F, Perez-Neut M, Colamonici OR. LIN-9 phosphorylation on threonine-96 is required for transcriptional activation of LIN-9 target genes and promotes cell cycle progression. Plos One. 9: e87620. PMID 24475316 DOI: 10.1371/journal.pone.0087620 |
0.576 |
|
| 2010 |
Song J, Sandoval R, Pilkinton MA, Tian X, Raychaudhuri P, Colamonici OR. ARF-induced downregulation of Mip130/LIN-9 protein levels mediates a positive feedback that leads to increased expression of p16Ink4a and p19Arf. Oncogene. 29: 1976-86. PMID 20101237 DOI: 10.1038/Onc.2009.485 |
0.703 |
|
| 2009 |
Sandoval R, Pilkinton M, Colamonici OR. Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex. Experimental Cell Research. 315: 2914-20. PMID 19619530 DOI: 10.1016/J.Yexcr.2009.07.014 |
0.699 |
|
| 2007 |
Pilkinton M, Sandoval R, Barrett K, Tian X, Colamonici OR. Mip/LIN-9 can inhibit cell proliferation independent of the pocket proteins. Blood Cells, Molecules & Diseases. 39: 272-7. PMID 17618148 DOI: 10.1016/J.Bcmd.2007.05.006 |
0.701 |
|
| 2007 |
Pilkinton M, Sandoval R, Colamonici OR. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex. Oncogene. 26: 7535-43. PMID 17563750 DOI: 10.1038/Sj.Onc.1210562 |
0.709 |
|
| 2007 |
Pilkinton M, Sandoval R, Song J, Ness SA, Colamonici OR. Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1. The Journal of Biological Chemistry. 282: 168-75. PMID 17098733 DOI: 10.1074/Jbc.M609924200 |
0.674 |
|
| 2006 |
Sandoval R, Xue J, Tian X, Barrett K, Pilkinton M, Ucker DS, Raychaudhuri P, Kineman RD, Luque RM, Baida G, Zou X, Valli VE, Cook JL, Kiyokawa H, Colamonici OR. A mutant allele of BARA/LIN-9 rescues the cdk4-/- phenotype by releasing the repression on E2F-regulated genes. Experimental Cell Research. 312: 2465-75. PMID 16730350 DOI: 10.1016/J.Yexcr.2006.04.002 |
0.685 |
|
| 2005 |
Buonamici S, Li D, Mikhail FM, Sassano A, Platanias LC, Colamonici O, Anastasi J, Nucifora G. EVI1 abrogates interferon-alpha response by selectively blocking PML induction. The Journal of Biological Chemistry. 280: 428-36. PMID 15519999 DOI: 10.1074/Jbc.M410836200 |
0.382 |
|
| 2004 |
Datta A, Nag A, Pan W, Hay N, Gartel AL, Colamonici O, Mori Y, Raychaudhuri P. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. The Journal of Biological Chemistry. 279: 36698-707. PMID 15199070 DOI: 10.1074/Jbc.M312305200 |
0.543 |
|
| 2004 |
Sandoval R, Xue J, Pilkinton M, Salvi D, Kiyokawa H, Colamonici OR. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines. The Journal of Biological Chemistry. 279: 32275-80. PMID 15169789 DOI: 10.1074/Jbc.M313830200 |
0.666 |
|
| 2001 |
Prejean C, Sarma T, Kurnasov O, Usacheva A, Hemmings B, Cantley L, Fruman DA, Morrison LA, Buller RM, Colamonici OR. Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors Journal of Immunology. 167: 4553-4559. PMID 11591783 DOI: 10.4049/Jimmunol.167.8.4553 |
0.317 |
|
| 2000 |
Croze E, Usacheva A, Asarnow D, Minshall RD, Perez HD, Colamonici O. Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type I IFN receptor. Journal of Immunology (Baltimore, Md. : 1950). 165: 5127-32. PMID 11046044 DOI: 10.4049/Jimmunol.165.9.5127 |
0.357 |
|
| 2000 |
Russell-Harde D, Wagner TC, Rani MRS, Vogel D, Colamonici O, Ransohoff RM, Majchrzak B, Fish E, Perez HD, Croze E. Role of the intracellular domain of the human type I interferon receptor 2 chain (IFNAR2c) in interferon signaling. Expression of IFNAR2c truncation mutants in U5A cells Journal of Biological Chemistry. 275: 23981-23985. PMID 10825167 DOI: 10.1074/Jbc.M002518200 |
0.442 |
|
| 1997 |
Uddin S, Sher DA, Alsayed Y, Pons S, Colamonici OR, Fish EN, White MF, Platanias LC. Interaction of p59fyn with interferon-activated Jak kinases. Biochemical and Biophysical Research Communications. 235: 83-8. PMID 9196040 DOI: 10.1006/Bbrc.1997.6741 |
0.327 |
|
| 1997 |
Uddin S, Sweet M, Colamonici OR, Krolewski JJ, Platanias LC. The vav proto-oncogene product (p95vav) interacts with the Tyk-2 protein tyrosine kinase. Febs Letters. 403: 31-4. PMID 9038355 DOI: 10.1016/S0014-5793(97)00023-9 |
0.322 |
|
| 1994 |
Colamonici O, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski J. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Molecular and Cellular Biology. 14: 8133-42. PMID 7526154 DOI: 10.1128/Mcb.14.12.8133 |
0.383 |
|
| 1989 |
Tortora G, Clair T, Katsaros D, Ally S, Colamonici O, Neckers LM, Tagliaferri P, Jahnsen T, Robins RK, Cho-Chung YS. Induction of megakaryocytic differentiation and modulation of protein kinase gene expression by site-selective cAMP analogs in K-562 human leukemic cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 2849-52. PMID 2539602 DOI: 10.1073/Pnas.86.8.2849 |
0.406 |
|
| 1988 |
Tortora G, Tagliaferri P, Clair T, Colamonici O, Neckers LM, Robins RK, Cho-Chung YS. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines. Blood. 71: 230-3. PMID 2825845 |
0.313 |
|
| 1987 |
Trepel JB, Colamonici OR, Kelly K, Schwab G, Watt RA, Sausville EA, Jaffe ES, Neckers LM. Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells. Molecular and Cellular Biology. 7: 2644-8. PMID 3039354 DOI: 10.1128/MCB.7.7.2644 |
0.311 |
|
| Show low-probability matches. |